WEC
REGN icon

Winslow Evans & Crocker’s Regeneron Pharmaceuticals REGN Stock Holding History

Winslow Evans & Crocker’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$33K Buy
68
+8
+13% +$4.32K 0.01% 685
2020
Q3 		$34K Sell
60
-1,304
-96% -$791K 0.01% 531
2020
Q2 		$851K Buy
1,364
+1,032
+311% +$586K 0.23% 96
2020
Q1 		$164K Sell
332
-66
-17% -$27.2K 0.05% 261
2019
Q4 		$150K Sell
398
-292
-42% -$98.2K 0.04% 332
2019
Q3 		$192K Hold
690
– – 0.05% 286
2019
Q2 		$216K Sell
690
-118
-15% -$39.3K 0.06% 282
2019
Q1 		$332K Sell
808
-98
-11% -$40.4K 0.09% 215
2018
Q4 		$340K Sell
906
-160
-15% -$58.6K 0.11% 190
2018
Q3 		$432K Hold
1,066
– – 0.13% 168
2018
Q2 		$368K Hold
1,066
– – 0.12% 183
2018
Q1 		$367K Buy
1,066
+232
+28% +$80.7K 0.12% 176
2017
Q4 		$313K Buy
834
+32
+4% +$13K 0.1% 203
2017
Q3 		$358K Buy
+802
New +$382K 0.12% 182
2016
Q4 		– Sell
-250
Closed -$101K – 1305
2016
Q3 		$101K Hold
250
– – 0.03% 406
2016
Q2 		$87.3K Hold
250
– – 0.03% 412
2016
Q1 		$90.1K Hold
250
– – 0.03% 389
2015
Q4 		$136K Hold
250
– – 0.04% 350
2015
Q3 		$116K Hold
250
– – 0.04% 365
2015
Q2 		$128K Sell
250
-14
-5% -$6.83K 0.04% 380
2015
Q1 		$119K Hold
264
– – 0.03% 396
2014
Q4 		$108K Buy
+264
New +$104K 0.03% 401
2014
Q3 		– Sell
-13
Closed -$3.67K – 1427
2014
Q2 		$3.67K Buy
+13
New +$3.85K ﹤0.01% 1095

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Winslow Evans & Crocker's REGN Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Regeneron Pharmaceuticals (REGN) stake by 13% in Q4 2020, buying an estimated $4.32K and bringing the position to 68 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #685.

Winslow Evans & Crocker first reported a position in REGN in Q2 2014 and has held it in 23 quarters since. The position peaked at $851K in Q2 2020. 903 funds tracked by Wall St. Rank hold REGN as of Q4 2020.

  • Winslow Evans & Crocker held 68 shares of Regeneron Pharmaceuticals worth $33K as of Q4 2020.
  • Winslow Evans & Crocker bought 8 Regeneron Pharmaceuticals shares in Q4 2020, an estimated $4.32K.
  • Regeneron Pharmaceuticals made up 0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #685 holding.
  • Winslow Evans & Crocker first reported a position in Regeneron Pharmaceuticals in Q2 2014 and has held it in 23 quarters since.
  • Winslow Evans & Crocker's Regeneron Pharmaceuticals position peaked at $851K in Q2 2020.
  • 903 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.